{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Plasmodium falciparum", "Malaria", "caffeic acid", "ethyl caffeate"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30033538", "DateCompleted": {"Year": "2018", "Month": "12", "Day": "31"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "07", "Day": "22"}], "Language": ["eng"], "ELocationID": ["10.1111/jphp.12982"], "Journal": {"ISSN": "2042-7158", "JournalIssue": {"Volume": "70", "Issue": "10", "PubDate": {"Year": "2018", "Month": "Oct"}}, "Title": "The Journal of pharmacy and pharmacology", "ISOAbbreviation": "J Pharm Pharmacol"}, "ArticleTitle": "In-vitro and in-vivo antimalarial activity of caffeic acid and some of its derivatives.", "Pagination": {"StartPage": "1349", "EndPage": "1356", "MedlinePgn": "1349-1356"}, "Abstract": {"AbstractText": ["To explore the in-vitro and in-vivo antimalarial potential of caffeic acid and derivatives.", "Two common phenolic acids (caffeic acid and chlorogenic acid) were evaluated for in-vitro and in-vivo antiplasmodial activity in comparison with some semi-synthetic derivatives that were synthesized. An in-vitro assay based on plasmodial lactate dehydrogenase activity, and the classical in-vivo 5-day suppressive test from Peters on an artemisinin-resistant Plasmodium berghei strain was used. Parasitic stage sensitivity to ethyl caffeate was determined in this work.", "Phenolic acid esters derivatives showed better antiplasmodial activity than corresponding phenolic acids. The derivative with the highest in-vitro activity being caffeic acid ethyl ester, exhibiting an IC<sub>50</sub> \u00a0=\u00a021.9\u00a0\u00b1\u00a09.4\u00a0\u03bcm. Ethyl caffeate and methyl caffeate were then evaluated for antimalarial activity in\u00a0vivo and ethyl caffeate showed a growth inhibition of 55% at 100\u00a0mg/kg. Finally, it seems that ethyl caffeate blocks the growth of young parasitic forms.", "Our study provides evidence for an antimalarial potential of caffeic acid derivatives which are common in several medicinal plants traditionally used against malaria. It also demonstrates the possibility to use such derivatives in the treatment of malaria."], "CopyrightInformation": "\u00a9 2018 Royal Pharmaceutical Society."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratoire de pharmacognosie, Centre Interdisciplinaire de Recherches sur les M\u00e9dicaments (CIRM), Universit\u00e9 de Li\u00e8ge, Li\u00e8ge, Belgium."}, {"Identifier": [], "Affiliation": "Laboratoire d'\u00c9valuation Pharmaco Clinique (LEPC), Institut Malgache de Recherches Appliqu\u00e9es (IMRA), Fondation Albert et Suzanne Rakoto-Ratsimamanga, Antananarivo, Madagascar."}], "LastName": "Alson", "ForeName": "Sylvain G", "Initials": "SG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratoire de pharmacognosie, Centre Interdisciplinaire de Recherches sur les M\u00e9dicaments (CIRM), Universit\u00e9 de Li\u00e8ge, Li\u00e8ge, Belgium."}], "LastName": "Jansen", "ForeName": "Olivia", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratoire de pharmacognosie, Centre Interdisciplinaire de Recherches sur les M\u00e9dicaments (CIRM), Universit\u00e9 de Li\u00e8ge, Li\u00e8ge, Belgium."}], "LastName": "Cieckiewicz", "ForeName": "Ewa", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratoire d'\u00c9valuation Pharmaco Clinique (LEPC), Institut Malgache de Recherches Appliqu\u00e9es (IMRA), Fondation Albert et Suzanne Rakoto-Ratsimamanga, Antananarivo, Madagascar."}], "LastName": "Rakotoarimanana", "ForeName": "Hajatiana", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratoire d'\u00c9valuation Pharmaco Clinique (LEPC), Institut Malgache de Recherches Appliqu\u00e9es (IMRA), Fondation Albert et Suzanne Rakoto-Ratsimamanga, Antananarivo, Madagascar."}], "LastName": "Rafatro", "ForeName": "Herintsoa", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratoire de pharmacognosie, Centre Interdisciplinaire de Recherches sur les M\u00e9dicaments (CIRM), Universit\u00e9 de Li\u00e8ge, Li\u00e8ge, Belgium."}, {"Identifier": [], "Affiliation": "Laboratoire de Chimie Pharmaceutique, Centre Interdisciplinaire de Recherches sur les M\u00e9dicaments (CIRM), Universit\u00e9 de Li\u00e8ge, Li\u00e8ge, Belgium."}], "LastName": "Degotte", "ForeName": "Gilles", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratoire de Chimie Pharmaceutique, Centre Interdisciplinaire de Recherches sur les M\u00e9dicaments (CIRM), Universit\u00e9 de Li\u00e8ge, Li\u00e8ge, Belgium."}], "LastName": "Francotte", "ForeName": "Pierre", "Initials": "P"}, {"Identifier": ["0000-0002-0770-9990"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratoire de pharmacognosie, Centre Interdisciplinaire de Recherches sur les M\u00e9dicaments (CIRM), Universit\u00e9 de Li\u00e8ge, Li\u00e8ge, Belgium."}], "LastName": "Frederich", "ForeName": "Michel", "Initials": "M"}], "GrantList": [{"GrantID": "FSRC-16/39", "Agency": "University of Li\u00e8ge Research Grants", "Country": ""}, {"GrantID": "T.0190.13", "Agency": "Belgian Fund for Scientific Research", "Country": ""}, {"Agency": "FRIA-FRS-FNRS", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Pharm Pharmacol", "NlmUniqueID": "0376363", "ISSNLinking": "0022-3573"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antimalarials"}, {"RegistryNumber": "0", "NameOfSubstance": "Caffeic Acids"}, {"RegistryNumber": "318ADP12RI", "NameOfSubstance": "Chlorogenic Acid"}, {"RegistryNumber": "3843-74-1", "NameOfSubstance": "methyl caffeate"}, {"RegistryNumber": "76GBB1JU5Y", "NameOfSubstance": "ethyl caffeate"}, {"RegistryNumber": "U2S3A33KVM", "NameOfSubstance": "caffeic acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antimalarials"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Caffeic Acids"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Chlorogenic Acid"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Parasitic Sensitivity Tests"}, {"QualifierName": ["drug effects"], "DescriptorName": "Plasmodium berghei"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2018", "Month": "4", "Day": "5"}, {"Year": "2018", "Month": "6", "Day": "27"}, {"Year": "2018", "Month": "7", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "24", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30033538", "10.1111/jphp.12982"]}}]}